CRC 1526, Project B01: Site-specific inhibition of C5/C5a in pemphigoid diseases

  • Ludwig, Ralf (Principal Investigator (PI))
  • Peipp, Matthias (Principal Investigator (PI))

Project: DFG ProjectsDFG Joint Research: Collaborative Research Center/ Transregios

Project Details

Description

Complement proteins C5 and C5a are key drivers of the effector phase of the pathogenesis of pemphigoid diseases (PD), but the systemic inhibition of C5/C5a may be associated with severe infections. To generate site-specific therapeutics, antibody fragments against PD autoantigens will be fused with those against C5/C5a, resulting in classical bispecific antibodies and hemibodies which only assemble a second functional antibody domain after binding to their targets. The therapeutic potential of these novel reagents will be evaluated in vitro, ex vivo, and in different mouse models of PDs.
StatusActive
Effective start/end date01.01.22 → …

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)
  • Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

  • 204-05 Immunology
  • 205-19 Dermatology

Funding Institution

  • DFG: German Research Association